A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors
NCT06394622
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor
Interventions
COMBINATION_PRODUCT:
Cyclophosphamide + Fludarabine + Infusion of CAR-NKT Cells
Sponsor
Fudan University